Puig: Undervalued With Growth Ahead

Summary Puig trades at a nearly 60% discount to Estée Lauder despite a similar prestige positioning and category mix. APAC delivered half of Puig’s revenue growth, up 21%, making it the only peer to grow significantly in the region while others declined. DCF and multiples-based valuation suggest a 58% upside to ~€26.9, with M&A capacity of €831m–1.7bn and a strategic focus on inorganic growth. Key risks include APAC demand slowdown, regulatory/tariff exposure, and the need for impactful M&A to sustain growth momentum. Tony Anderson/DigitalVision via Getty Images Investment Thesis Asia-Pacific delivered half of Puig's ( PUIGF )( PUGBY ) revenue growth, up 21%, while every peer fell in the region. Essentially a structural twin for Estée Lauder ( EL ), the company This article was written by Salome Gigiberia 54 Followers Follow I am a finance graduate with a focus on event-driven investing and special situations across European and emerging markets. My research centres on catalyst-rich opportunities where mispricing arises from corporate actions, complex capital structures, or temporary dislocations rather than from broad sector themes. The situations I find most compelling include public M&A and announced takeovers, contested bids and shareholder activism, spin-offs and corporate separations, post-reorganisation equities, regulatory or litigation catalysts, and stressed or distressed credit with equity-like upside. I am sector-agnostic by design, as event-driven analysis rewards bottom-up rigour on the specific situation rather than top-down sector calls, though I have spent meaningful time on financials, industrials, and consumer names where corporate activity has been most concentrated. My approach combines primary-source diligence - regulatory filings, court documents, shareholder registers, and proxy materials - with disciplined scenario analysis around deal probability, downside breaks, and timing risk. I place particular emphasis on understanding the marginal buyer and seller in any given situation, and on identifying where consensus is anchored to outdated assumptions. I write on Seeking Alpha to share structured, evidence-based perspectives on situations I am actively researching, to invite scrutiny from a thoughtful readership, and to contribute to a higher-quality discussion of special-situations investing beyond headline-driven commentary. Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.